Koskinen S, Enockson C, Lopes-Virella M F, Virella G
Division of Endocrinology, Diabetes and Medical Genetics, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Clin Diagn Lab Immunol. 1998 Nov;5(6):817-22. doi: 10.1128/CDLI.5.6.817-822.1998.
As part of our ongoing effort to develop a standardized competitive enzyme immunoassay for human autoantibodies to oxidized low-density lipoprotein (oxLDL), we have generated a reference human antibody standard and revised some of the conditions of the assay. The preparation of the standard involved purification of human anti-oxLDL antibodies by affinity chromatography using immobilized oxLDL. The total concentration of antibody in this purified human oxLDL antibody was established by adding the concentrations of immunoglobulin G (IgG), IgA, and IgM determined in the standard by radial immunodiffusion. The isolated antibody was used to calibrate a whole human serum standard, which was used to calibrate the assays to detect antibody in serum samples. We also revisited the general conditions for performance of our competitive assay. We determined that 1/20 was the ideal dilution for performing the absorption step, and that 1/20 and 1/40 were optimal dilutions to assay oxLDL antibody in unknown serum samples. We also established that the optimal concentration of oxLDL for absorption of free antibody in serum samples was 200 microgram of oxLDL/ml; no significant decrease in the reactivity of samples with immobilized oxLDL was observed when higher concentrations of oxLDL were used for absorption. The minimum detection level of the assay is 0.65 mg/liter. Because serum samples are diluted 1/20 and 1/40 for the assay, the minimal concentration of antibody detectable in serum is 20-fold higher, i.e., 13 mg/liter. The intraassay coefficient of variation calculated from seven determinations of three samples containing antibody concentrations of 240, 340, and 920 mg/liter ranged from 8 to 6.1%. The interassay coefficients of variation for sera with antibody levels of 100 to 594 mg/liter varied from 9.2 to 7.0%, and for isolated antibodies with concentrations of 52 to 111 mg/liter, the coefficients varied from 5.8 to 3.9%.
作为我们持续努力开发一种针对人抗氧化型低密度脂蛋白(oxLDL)自身抗体的标准化竞争性酶免疫测定方法的一部分,我们制备了一种人源抗体标准品,并修订了该测定方法的一些条件。标准品的制备包括使用固定化oxLDL通过亲和色谱法纯化人抗oxLDL抗体。通过添加放射免疫扩散法测定标准品中免疫球蛋白G(IgG)、IgA和IgM的浓度,确定了这种纯化的人oxLDL抗体中抗体的总浓度。分离出的抗体用于校准全人血清标准品,该标准品用于校准检测血清样品中抗体的测定方法。我们还重新审视了竞争性测定方法的一般条件。我们确定1/20是进行吸收步骤的理想稀释度,1/20和1/40是测定未知血清样品中oxLDL抗体的最佳稀释度。我们还确定血清样品中用于吸收游离抗体的oxLDL的最佳浓度为200微克oxLDL/毫升;当使用更高浓度的oxLDL进行吸收时,未观察到样品与固定化oxLDL的反应性有显著降低。该测定方法的最低检测水平为0.65毫克/升。由于血清样品在测定时稀释了1/20和1/40,血清中可检测到的抗体最低浓度高出20倍,即13毫克/升。从对三个抗体浓度分别为240、340和920毫克/升的样品进行七次测定计算得出的批内变异系数范围为8%至6.1%。抗体水平为100至594毫克/升的血清的批间变异系数在9.2%至7.0%之间变化,对于浓度为52至111毫克/升的分离抗体,变异系数在5.8%至3.9%之间变化。